Banner

Thyroid Cancer Drugs Global Market Report 2023 – By Drug Type (Ipilimumab, CabozantinibSMalate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types), By End Users (Hospitals, Oncology Clinics, Research Organizations, Other EndUsers), By Type (Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Other Types) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | SKU CODE : r756 | Delivery Time: 2-3 business days | Format :


The thyroid cancer drugs refer to drugs that are used to treat thyroid cancer by blocking several different kinase proteins. These medications function primarily in two ways. First, they aid in preventing tumours from growing new blood vessels, which they require to do so. They target a few of the proteins that cancer cells often produce to aid in their growth. The thyroid tissue is made up of follicular cells and parafollicular cells in which cancer develops.

The main types of thyroid cancer drugs are radioiodine ablation, thyroid stimulating hormone (THS) suppression, chemotherapy, targeted multikinase therapy, and others. Radioiodine ablation is a type of radiation therapy that uses radioactive iodine to remove or ablate any healthy thyroid tissue that remains following a thyroidectomy. The different types of drugs include ipilimumab, cabozantinib-s-malate, caprelsa (vandetanib), doxorubicin hydrochloride, and lenvatinibmesylate, nivolumab, vandetanib, others and are used in various sectors such as hospitals, oncology clinics, research organizations, others.

The thyroid cancer drugs market research report is one of a series of new reports from The Business Research Company that provides thyroid cancer drugs market statistics, including thyroid cancer drugs industry global market size, regional shares, competitors with a thyroid cancer drugs market share, detailed thyroid cancer drugs market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer drugs industry. This thyroid cancer drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global thyroid cancer drugs market size will grow from $0.71 billion in 2022 to $0.81 billion in 2023 at a compound annual growth rate (CAGR) of 14.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global thyroid cancer drugs market size is expected to grow to $1.29 billion in 2027 at a CAGR of 12.5%.

Increasing incidences of thyroid cancer, especially in women are driving the thyroid cancer drugs market.Forinstance,in 2022, according to The American Cancer Society, a US-based organization, Approximately 43,800 new cases of thyroid cancer were estimated in the United States, which are 31,940 cases in women and 11,860 cases in men with 2,230 deaths from thyroid cancer, among those deaths, 1,070 are of men and 1,160 deaths are of women. Therefore, increasing incidences of thyroid cancer, especially in women drives the thyroid cancer market..

Increasing the use of targeted therapies for the treatment of thyroid cancer is acting as a restraint on the thyroid cancer drugs market. Targeted therapies target cancer-specific genes, proteins, and tissues that promote cancer growth and survival. Targeted therapies are increasingly being used to treat thyroid cancer as thyroid hormone-based treatments including radioactive iodine therapy are not effective against these cancers. For example, Vandetanib (Caprelsa) and Cabozantinib (Cometriq) are targeted therapies used to treat advanced medullary thyroid cancer (MTC). As patients increasingly use targeted therapies for treatment, demand for thyroid cancer drugs is decreasing, affecting the market growth.

Combination drugs are increasingly being used in the treatment of thyroid cancer as they are more effective and help prevent cancer progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance and prevent the growth of cancer cells. For instance, the FDA approved the combination of dabrafenib (Tafinlar), a BRAF inhibitor, and trametinib (Mekinist), a MEK inhibitor for the treatment of anaplastic thyroid cancer.

Manufacturers of thyroid cancer drugs are governed by regulatory authorities such as the Food and Drug Administration in the USA. For instance, off-label usage of FDA-approved drugs for the treatment of cancer requires approval from the FDA. Manufacturers are required to submit a supplemental marketing application called sNDA (Supplemental New Drug Application) to the FDA that approves the drug for a prescription.

In August 2022, Bristol Myers Squibb, a US-based pharmaceutical company acquired Turning Point Therapeutics for an undisclosed amount. Through this acquisition, BMS expands its portfolio in developing precision medicine for cancer patients. Turning Point Therapeutics is a US-based company developing cancer drugs that also include thyroid cancer drugs.

Major players in the thyroid cancer drugs market are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc., Baxter International Inc., Abbott laboratories, App pharmaceuticals llc., AstraZeneca PLC and GlaxoSmithKline PLC.

North America was the largest region in the thyroid cancer drugs market in 2022. Middle East is expected to be the fastest-growing region in the global thyroid cancer drugs market during the forecast period. The regions covered in the global thyroid cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the thyroid cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The thyroid cancer drugs market consists of sales cabozantinib-s-malate, caprelsa, and cometriq.Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global thyroid cancer drugs market is segmented -

1) By Drug Type: Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types

2) By End Users: Hospitals, Oncology Clinics, Research Organizations, Other End-Users

3) By Type: Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Other Types

    Table Of Contents

    1. Executive Summary

    2. Thyroid Cancer Drugs Market Characteristics

    3. Thyroid Cancer Drugs Market Trends And Strategies

    4. Thyroid Cancer Drugs Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Thyroid Cancer Drugs Market

    4.2 Ukraine-Russia War Impact On Thyroid Cancer Drugs Market

    4.3 Impact Of High Inflation On Thyroid Cancer Drugs Market

    5. Thyroid Cancer Drugs Market Size And Growth

    5.1. Global Thyroid Cancer Drugs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Thyroid Cancer Drugs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Thyroid Cancer Drugs Market Segmentation

    6.1. Global Thyroid Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Ipilimumab

    Cabozantinib-S-Malate

    Caprelsa (Vandetanib)

    Doxorubicin Hydrochloride

    Lenvatinib Mesylate

    Nivolumab

    Vandetanib

    Other Drug Types

    6.2. Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Oncology Clinics

    Research Organizations

    Other End Users

    6.3. Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Radioiodine Ablation

    Thyroid Stimulating Hormone (THS) Suppression

    Chemotherapy

    Targeted Multikinase Therapy

    Other Types

    7. Thyroid Cancer Drugs Market Regional And Country Analysis

    7.1. Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Thyroid Cancer Drugs Market

    8.1. Asia-Pacific Thyroid Cancer Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.4. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Thyroid Cancer Drugs Market

    9.1. China Thyroid Cancer Drugs Market Overview

    9.2. China Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.4. China Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Thyroid Cancer Drugs Market

    10.1. India Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.3. India Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Thyroid Cancer Drugs Market

    11.1. Japan Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.3. Japan Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Thyroid Cancer Drugs Market

    12.1. Australia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.3. Australia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Thyroid Cancer Drugs Market

    13.1. Indonesia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.3. Indonesia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Thyroid Cancer Drugs Market

    14.1. South Korea Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.3. South Korea Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Thyroid Cancer Drugs Market

    15.1. Western Europe Thyroid Cancer Drugs Market Overview

    15.2. Western Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.4. Western Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Thyroid Cancer Drugs Market

    16.1. UK Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.3. UK Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Thyroid Cancer Drugs Market

    17.1. Germany Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.3. Germany Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Thyroid Cancer Drugs Market

    18.5. France Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.6. France Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.7. France Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Thyroid Cancer Drugs Market

    19.1. Eastern Europe Thyroid Cancer Drugs Market Overview

    19.2. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.4. Eastern Europe Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Thyroid Cancer Drugs Market

    20.1. Russia Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.3. Russia Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Thyroid Cancer Drugs Market

    21.1. North America Thyroid Cancer Drugs Market Overview

    21.2. North America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.4. North America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Thyroid Cancer Drugs Market

    22.1. USA Thyroid Cancer Drugs Market Overview

    22.2. USA Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.4. USA Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Thyroid Cancer Drugs Market

    23.1. South America Thyroid Cancer Drugs Market Overview

    23.2. South America Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.4. South America Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Thyroid Cancer Drugs Market

    24.1. Brazil Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.3. Brazil Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Thyroid Cancer Drugs Market

    25.1. Middle East Thyroid Cancer Drugs Market Overview

    25.2. Middle East Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.4. Middle East Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Thyroid Cancer Drugs Market

    26.1. Africa Thyroid Cancer Drugs Market Overview

    26.2. Africa Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.4. Africa Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Thyroid Cancer Drugs Market Competitive Landscape And Company Profiles

    27.1. Thyroid Cancer Drugs Market Competitive Landscape

    27.2. Thyroid Cancer Drugs Market Company Profiles

    27.2.1. Mylan Pharmaceuticals Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Alara Pharmaceutical Corporation

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bristol Myers co.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Teva parenteral medicines Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Jerome Stevens Pharmaceuticals Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Thyroid Cancer Drugs Pipeline Analysis

    29. Key Mergers And Acquisitions In The Thyroid Cancer Drugs Market

    30. Thyroid Cancer Drugs Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: China, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: India, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: India, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Japan, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Japan, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Japan, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Australia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: Australia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Australia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Indonesia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: South Korea, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: South Korea, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: South Korea, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Western Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: UK, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: UK, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: UK, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: Germany, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: Germany, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: Germany, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: France, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: France, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: France, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Russia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Russia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Russia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: North America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 48: North America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 49: North America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 50: USA, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 51: USA, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 52: USA, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 53: South America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 54: South America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 55: South America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 56: Brazil, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 57: Brazil, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 58: Brazil, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 59: Middle East, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 60: Middle East, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 61: Middle East, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 62: Africa, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 63: Africa, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 64: Africa, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 65: Mylan Pharmaceuticals Inc. Financial Performance
  • Table 66: Alara Pharmaceutical Corporation Financial Performance
  • Table 67: Bristol Myers co. Financial Performance
  • Table 68: Teva parenteral medicines Inc. Financial Performance
  • Table 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: China, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: India, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: India, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Japan, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Japan, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Japan, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Australia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: Australia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Australia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Indonesia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Indonesia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: South Korea, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: South Korea, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: South Korea, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Western Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Western Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: UK, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: UK, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: UK, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: Germany, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: Germany, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: Germany, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: France, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: France, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: France, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Eastern Europe, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Russia, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Russia, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Russia, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: North America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 48: North America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 49: North America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 50: USA, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 51: USA, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 52: USA, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 53: South America, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 54: South America, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 55: South America, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 56: Brazil, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 57: Brazil, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 58: Brazil, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 59: Middle East, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 60: Middle East, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 61: Middle East, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 62: Africa, Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 63: Africa, Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 64: Africa, Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 65: Mylan Pharmaceuticals Inc. Financial Performance
  • Figure 66: Alara Pharmaceutical Corporation Financial Performance
  • Figure 67: Bristol Myers co. Financial Performance
  • Figure 68: Teva parenteral medicines Inc. Financial Performance
  • Figure 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report